Procept BioRobotics (PRCT) | Stock Overview & Key Data
Procept BioRobotics Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $103.81 on November 11, 2024
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Procept BioRobotics
PRCT
|
1.37B Small-cap | -2.48% | 7.81% | 3.36% | -9.35% | -12.97% | -54.60% | -18.98% | -34.18% | -34.18% | -34.18% | -34.18% |
| 160.70B Large-cap | 0.35% | -0.65% | -23.79% | -31.15% | -29.97% | -35.92% | -17.85% | -21.68% | 118.48% | 249.25% | 313.73% | |
|
Stryker
SYK
|
126.25B Large-cap | -6.29% | 0.83% | -24.22% | -20.01% | -15.76% | -20.27% | 9.63% | 21.15% | 168.66% | 406.79% | 583.29% |
|
Axogen
AXGN
|
1.94B Small-cap | -4.80% | -7.44% | 28.74% | 42.51% | 27.29% | 262.53% | 346.61% | 108.01% | 590.21% | 1,114.77% | 9,770.00% |
|
Establishment Labs
ESTA
|
1.91B Small-cap | -3.07% | 0.24% | -7.48% | 4.34% | 2.28% | 105.37% | 6.40% | -6.53% | 167.87% | 167.87% | 167.87% |
|
Artivion
AORT
|
1.83B Small-cap | -11.94% | -42.53% | -47.03% | -54.99% | -54.07% | -24.98% | 45.13% | -23.19% | 88.21% | 317.89% | 366.18% |
Ownership & Short Interest
Calculate Your Procept BioRobotics Investment Returns
Long-Term Investment Performance Analysis
Procept BioRobotics stock price in Sep 2021 was $40.00, A $1,000.00 lump sum investment in Procept BioRobotics made 4 years ago would be worth approximately $658.25 today, representing a negative return of -34.18%. This translates to an annualized return (CAGR) of -8.48%.
4 Years 8 Months Investment Scenario (Sep 2021 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is PRCT's 52-week high and low?
- In the last 52 weeks, Procept BioRobotics reached a high of $66.85 (on June 5, 2025) and a low of $19.35 (on February 26, 2026).
- What is the market cap and P/E ratio for PRCT?
- Curious about Procept BioRobotics's size and valuation? Its market capitalization stands at 1.37B. When it comes to valuation, the P/E ratio (trailing twelve months) is -14.09, and the forward P/E (looking ahead) is -28.38.
- Does PRCT pay dividends? If so, what's the yield?
- Yes, Procept BioRobotics is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.64%, and the company has paid an average of $0.53 per share annually over the past 3 years.
- Who are Procept BioRobotics's main competitors or similar companies to consider before investing?
When looking at Procept BioRobotics, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT160.70B Healthcare Medical Devices -35.92% -17.85% Stryker
SYK126.25B Healthcare Medical Devices -20.27% 9.63% Axogen
AXGN1.94B Healthcare Medical Devices 262.53% 346.61% Establishment Labs
ESTA1.91B Healthcare Medical Devices 105.37% 6.40% Artivion
AORT1.83B Healthcare Medical Devices -24.98% 45.13% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Procept BioRobotics Corporation? (e.g., ROE, Debt/Equity)
- To get a sense of Procept BioRobotics's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -24.89%, the Debt to Equity ratio from the most recent quarter is 21.45, and its Gross Profit Margin stands at 60.63%.
- What is the recent revenue and earnings growth for PRCT?
- Looking at Procept BioRobotics's growth, its revenue over the trailing twelve months (TTM) was $308M. Compared to the same quarter last year (YoY), quarterly revenue grew by 11.90%, and quarterly earnings saw a YoY growth of 11.94%.
- How much of PRCT stock is held by insiders and institutions?
- Wondering who owns Procept BioRobotics stock? Company insiders (like executives and directors) hold about 3.22% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 104.61%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.